Homestead Advisers Corp Sells 71,400 Shares of Envista Holdings Corporation $NVST

Homestead Advisers Corp lessened its holdings in Envista Holdings Corporation (NYSE:NVST) by 24.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 223,000 shares of the company’s stock after selling 71,400 shares during the period. Homestead Advisers Corp owned 0.13% of Envista worth $4,543,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in NVST. Optimize Financial Inc purchased a new stake in Envista during the 3rd quarter valued at approximately $406,000. Hantz Financial Services Inc. boosted its holdings in shares of Envista by 7.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 141,815 shares of the company’s stock valued at $2,889,000 after purchasing an additional 9,916 shares during the last quarter. Allianz Asset Management GmbH increased its holdings in shares of Envista by 21.3% in the third quarter. Allianz Asset Management GmbH now owns 568,988 shares of the company’s stock worth $11,590,000 after purchasing an additional 99,903 shares during the last quarter. Convergence Investment Partners LLC purchased a new stake in shares of Envista in the third quarter worth about $585,000. Finally, Keybank National Association OH boosted its stake in Envista by 13.5% during the third quarter. Keybank National Association OH now owns 21,621 shares of the company’s stock valued at $440,000 after buying an additional 2,575 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Robert W. Baird set a $27.00 price target on shares of Envista in a research note on Friday, October 31st. UBS Group upped their target price on shares of Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday. Stifel Nicolaus lifted their price target on Envista from $25.00 to $27.00 and gave the stock a “buy” rating in a research report on Wednesday. JPMorgan Chase & Co. boosted their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Tuesday, December 16th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $22.75.

Envista Stock Up 3.1%

Shares of NVST opened at $23.63 on Thursday. The firm has a fifty day moving average price of $22.56 and a 200-day moving average price of $21.14. The company has a current ratio of 2.37, a quick ratio of 2.02 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $3.89 billion, a P/E ratio of 262.58, a P/E/G ratio of 1.02 and a beta of 1.01. Envista Holdings Corporation has a 12-month low of $14.22 and a 12-month high of $25.41.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.